Certified by Founder
Lodge
Xenocor
start up
United States
- Salt Lake City, Utah
- 19/04/2023
- Series A
- $10,000,000
Xenocor is actively solving challenges in minimally invasive surgery by bringing the Saberscope single-use, fog-free, articulating laparoscopic platform to market.
Xenocor is a privately held corporation, based in Salt Lake City, UT. Learn more at: www.saberscope.com/resources
- Industry Medical Equipment Manufacturing
- Website https://xenocor.com/
- LinkedIn https://www.linkedin.com/company/xenocor/
Related People
Charles DeCoster IVFounder
United States -
Washington, Utah
Life Sciences senior leader specializing in Investor Relations, Strategy, Business Development/M&A, Upstream Marketing and Portfolio Management
Integrate | $17,000,000 | (Feb 13, 2026)
daypass.com | $2,000,000 | (Feb 13, 2026)
CYDELPHI | $3,000,000 | (Feb 13, 2026)
Maestro Tech, Inc. | $1,200,000 | (Feb 13, 2026)
Ever | $31,000,000 | (Feb 13, 2026)
Manufact (formerly mcp-use) | $6,300,000 | (Feb 13, 2026)
Reflow | $15,000,000 | (Feb 13, 2026)
Santé(US) | $7,600,000 | (Feb 13, 2026)
Alva Energy | $33,000,000 | (Feb 13, 2026)
Project Omega | $12,000,000 | (Feb 13, 2026)
Brandlight | $30,000,000 | (Feb 12, 2026)
Inertia | $450,000,000 | (Feb 12, 2026)